Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences - 1 Sept 2005

Su Guan-guan, Zhao Nian-fen, Zhou Yong, Ying Mei-fang

Abstract excerpt

OBJECTIVE: To evaluate the efficacy and safety of adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD motif mutation during lamivudine therapy. METHODS: The disease relapsed in 14 hepatitis B patients with decompensated liver cirrhosis during lamivudine treatment d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to DNA-Directed DNA Polymerase
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Liver Cirrhosis

Share to Organophosphonates

Share to Recurrence

Share to Reverse Transcription

Source

Identifiers

PMID: 16216062
DOI: 10.3785/j.issn.1008-9292.2005.05.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-16216062-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation].PMID 16216062Read ↗

[A study on the treatment of chronic hepatitis B with YMDD mutation].Semantic proximity Read ↗

[Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].Semantic proximity Read ↗

[A study on the mutation of P gene region including YMDD motif in hepatitis B virus].Semantic proximity Read ↗

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].Semantic proximity Read ↗

[Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].Semantic proximity Read ↗

[Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].Semantic proximity Read ↗

[Emergence and clinical significance of YMDD and HBeAg-related mutations during lamivudine treatment].Semantic proximity Read ↗

Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.Semantic proximity Read ↗

Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.Semantic proximity Read ↗

The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis.Semantic proximity Read ↗

[Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].Semantic proximity Read ↗

Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.